Search research articles
Contact Us
Filters
Showing results (111-120 of 123) with videos related to
Page
of 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
October 10, 2022
A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery
Evan Rosenbaum, Rashmi Chugh, Christopher W Ryan, et al.
NPJ Precision Oncology
|
May 5, 2026
An international framework for clinical translation of molecular classifiers in osteosarcoma
Amanda E Marinoff, Michaela Nathrath, David S Shulman, et al.
JAMA Oncology
|
July 8, 2021
Association of Combination of Conformation-Specific KIT Inhibitors With Clinical Benefit in Patients With Refractory Gastrointestinal Stromal Tumors: A Phase 1b/2a Nonrandomized Clinical Trial
Andrew J Wagner, Paul L Severson, Anthony F Shields, et al.
JAMA Oncology
|
February 25, 2021
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors
Erin F Cobain, Yi-Mi Wu, Pankaj Vats, et al.
Oncotarget
|
November 23, 2017
Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy
Daniel H Hovelson, Chia-Jen Liu, Yugang Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 4, 2018
Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Peter F Coccia, Alberto S Pappo, Lynda Beaupin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2021
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609)
Sylvia Adams, Megan Othus, Sandip Pravin Patel, et al.
Nature
|
August 8, 2017
Integrative clinical genomics of metastatic cancer
Dan R Robinson, Yi-Mi Wu, Robert J Lonigro, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 7, 2023
Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Smita Bhatia, Alberto S Pappo, Melissa Acquazzino, et al.
Nature Medicine
|
April 16, 2026
Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial
Patrick J Grohar, Rachel Heise, Mary Frances Wedekind, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 123) with videos related to
Sort By:
Page
of 13
European Journal of Cancer (Oxford, England : 1990)
|
October 10, 2022
A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery
Evan Rosenbaum, Rashmi Chugh, Christopher W Ryan, et al.
NPJ Precision Oncology
|
May 5, 2026
An international framework for clinical translation of molecular classifiers in osteosarcoma
Amanda E Marinoff, Michaela Nathrath, David S Shulman, et al.
JAMA Oncology
|
July 8, 2021
Association of Combination of Conformation-Specific KIT Inhibitors With Clinical Benefit in Patients With Refractory Gastrointestinal Stromal Tumors: A Phase 1b/2a Nonrandomized Clinical Trial
Andrew J Wagner, Paul L Severson, Anthony F Shields, et al.
JAMA Oncology
|
February 25, 2021
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors
Erin F Cobain, Yi-Mi Wu, Pankaj Vats, et al.
Oncotarget
|
November 23, 2017
Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy
Daniel H Hovelson, Chia-Jen Liu, Yugang Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 4, 2018
Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Peter F Coccia, Alberto S Pappo, Lynda Beaupin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2021
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609)
Sylvia Adams, Megan Othus, Sandip Pravin Patel, et al.
Nature
|
August 8, 2017
Integrative clinical genomics of metastatic cancer
Dan R Robinson, Yi-Mi Wu, Robert J Lonigro, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 7, 2023
Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Smita Bhatia, Alberto S Pappo, Melissa Acquazzino, et al.
Nature Medicine
|
April 16, 2026
Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial
Patrick J Grohar, Rachel Heise, Mary Frances Wedekind, et al.
Page
of 13